| Name | Title | Contact Details |
|---|
TD Bank Convention Center is a Greenville, SC-based company in the Business Services sector.
The Aurora De Juliis, M.D. European Medical-Spa is a Bloomfield, NJ-based company in the Business Services sector.
Mintz Filiates is a Coram, NY-based company in the Business Services sector.
AHEAD is a prominent IT services and consulting company that assists enterprises in accelerating their digital transformation. Established in 2007 and headquartered in Illinois, AHEAD has grown significantly, employing between 1,001 and 5,000 people across the United States and globally. The company specializes in strategic consulting and managed services, focusing on cloud, security, data, and automation to help clients enhance customer experiences and improve operational efficiency. AHEAD offers a wide range of services, including strategic consulting to align technology with business goals, managed services for optimizing digital platforms, and cloud services for migration and management. The company also provides cybersecurity solutions and supports data-driven initiatives and automation to boost business agility. AHEAD collaborates with major technology partners like NetApp and AWS to deliver comprehensive solutions, leveraging advanced technologies and best practices in the industry.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.